To the Editor We read with interest the article of Sims et al,¹ who reported that low-dose supplementation of arginine vasopressin reduced blood transfusion products and mortality in patients with traumatic hemorrhagic shock in their article in JAMA Surgery.¹ Regarding the application of low-dose vasopressin for trauma patients in clinical practice, we should discuss some points referring to previous clinical studies.

中文翻译：

---

小剂量加压素在创伤性失血性休克临床应用中的问题。

致编辑我们感兴趣地阅读了Sims等人的文章[ ^1]，他在JAMA Surgery中的文章中报道了低剂量补充精氨酸加压素降低了创伤性失血性休克患者的输血产品和死亡率。¹关于小剂量加压素在创伤患者中的临床应用，我们应参考先前的临床研究讨论一些要点。